34 related articles for article (PubMed ID: 10997815)
1. Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma).
Zinzani PL; Derenzini E; Pellegrini C; Rigacci L; Fabbri A; Gandolfi L; Argnani L; Casadei B; Pulsoni A; Gobbi M; Perotti A; Zaccaria A; Voso MT; Cabras MG; De Renzo A
Ann Oncol; 2012 Mar; 23(3):805-807. PubMed ID: 22287683
[No Abstract] [Full Text] [Related]
2. Assessment of Correlation Between Early and Late Efficacy Endpoints to Identify Potential Surrogacy Relationships in Non-Hodgkin Lymphoma: a Literature-Based Meta-analysis of 108 Phase II and Phase III Studies.
Zhu R; Lu D; Chu YW; Chai A; Green M; Zhang N; Jin JY
AAPS J; 2017 May; 19(3):669-681. PubMed ID: 28224402
[TBL] [Abstract][Full Text] [Related]
3. Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care.
Pettengell R; Aapro M; Brusamolino E; Caballero D; Coiffier B; Pfreundschuh M; Trneny M; Walewski J
Clin Drug Investig; 2009; 29(8):491-513. PubMed ID: 19591512
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine: a review of its use in non-Hodgkin's lymphoma.
Anderson VR; Perry CM
Drugs; 2007; 67(11):1633-55. PubMed ID: 17661532
[TBL] [Abstract][Full Text] [Related]
5. Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI).
Yung L; Cunningham D; Hancock B; Smith P; Maclennan K; Linch D; McMillan A
Br J Cancer; 2004 Aug; 91(4):695-8. PubMed ID: 15280929
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of disease involvement by follicular lymphoma using real-time polymerase chain reaction measurement of t(14;18)-carrying cells.
Lee WI; Cabanillas F; Lee MS
Int J Hematol; 2004 Feb; 79(2):152-6. PubMed ID: 15005343
[TBL] [Abstract][Full Text] [Related]
7. The role of mitoxantrone in the treatment of indolent lymphomas.
Hagemeister F; Cabanillas F; Coleman M; Gregory SA; Zinzani PL
Oncologist; 2005 Feb; 10(2):150-9. PubMed ID: 15709217
[TBL] [Abstract][Full Text] [Related]
8. Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND).
Keating MJ; McLaughlin P; Cabanillas F
Eur J Cancer Care (Engl); 1997 Dec; 6(4 Suppl):21-6. PubMed ID: 9460339
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma.
Wilder DD; Ogden JL; Jain VK
Clin Lymphoma; 2002 Mar; 2(4):229-37. PubMed ID: 11970762
[TBL] [Abstract][Full Text] [Related]
10. The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival.
Bishton MJ; Rule S; Wilson W; Turner D; Patmore R; Clifton-Hadley L; McMillan A; Lush R; Haynes A
Br J Haematol; 2020 Aug; 190(4):545-554. PubMed ID: 32150649
[TBL] [Abstract][Full Text] [Related]
11. Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group.
Santini G; Chisesi T; Nati S; Porcellini A; Zoli V; Rizzoli V; Zupo S; Marino G; Rubagotti A; Polacco A; Spriano M; Vimercati R; Congiu AM; Ravetti JL; Aversa S; Candela M; Patti C
Leuk Lymphoma; 2004 Jun; 45(6):1141-7. PubMed ID: 15359993
[TBL] [Abstract][Full Text] [Related]
12. Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.
Zinzani PL; Pellegrini C; Broccoli A; Casadei B; Argnani L; Pileri S
Am J Hematol; 2013 Nov; 88(11):E273-6. PubMed ID: 23843267
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.
McLaughlin P; Hagemeister FB; Swan F; Cabanillas F; Pate O; Romaguera JE; Rodriguez MA; Redman JR; Keating M
J Clin Oncol; 1994 Mar; 12(3):575-9. PubMed ID: 8120556
[TBL] [Abstract][Full Text] [Related]
14. A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma.
Crawley CR; Foran JM; Gupta RK; Rohatiner AZ; Summers K; Matthews J; Micallef IN; Radford JA; Johnson SA; Johnson PW; Sweetenham JW; Lister TA
Ann Oncol; 2000 Jul; 11(7):861-5. PubMed ID: 10997815
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
